These kinds of genetically designed therapies will require some major retooling of infrastructure, capital, regulation, etc., but are fundamentally cheap and cu

These kinds of genetically designed therapies will require some major retooling of infrastructure, capital, regulation, etc., but are fundamentally cheap and curative - for mis/dis-regulation of the body's own systems. Ultimately, the material to be delivered is extraordinarily cheap to produce. There is a LOT of capital that must be recouped to get these innovations up and running, but in time they should dramatically drop in price and accessibility.